Avid Bioservices Inc (CDMO)

[eb0783]

I agree that Peregrine has done much better than the average BP/biotech. Was this comment an attempt to be disparaging to Peregrine or a try to make us think Peregrine is worse than most BPs/biotechs, a terrible company?:

This company has lost over one half billion

Really this should bring it home to us:

A new report published by the Tufts Center for the Study of Drug Development (CSDD) pegs the cost of developing a prescription drug that gains market approval at $2.6 billion

Again, I agree that Peregrine has done much better than the average BP/biotech. C'mon man!